Divisas / GMAB
GMAB: Genmab A/S - American Depositary Shares
21.86
USD
0.18
(0.83%)
El tipo de cambio de GMAB de hoy ha cambiado un 0.83%. En este caso, el precio mínimo en el mercado ha alcanzado 21.53, mientras que el máximo ha alcanzado 21.89.
Siga la dinámica de la pareja de divisas Genmab A/S - American Depositary Shares. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
GMAB News
- Investing Denmark stocks higher at close of trade; OMX Copenhagen 20 up 1.18%
- Investing Truist Securities raises Genmab stock price target to $46 on strong revenue outlook
- Investing M.Stanley takes neutral stance on Genmab ahead of portfolio, execution updates
- Investing Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.80%
- Investing Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.20%
- Investing Genmab completes share buy-back program, repurchases 2.2 million shares
- Seeking Alpha Genmab: This Is Anything But A Value Trap, Yet It Is Currently Priced As One (NASDAQ:GMAB)
- Investing Capital Increase in Genmab as a Result of Employee Warrant Exercise
- Investing Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
- Investing Transactions in Connection with Share Buy-back Program
- Investing Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.71%
- Investing Genmab awards stock units and warrants to employees
- Investing Genmab grants restricted stock units and warrants to employees
- Investing Genmab details share buy-back transactions
- Investing Transactions in Connection with Share Buy-back Program
- Investing Leerink Partners raises Genmab stock price target to $32 from $29
- Investing Stifel reiterates buy rating for Zymeworks stock after ASCO meeting
- Investing Stifel analysts reaffirm Zymeworks stock buy rating after ASCO update
- Investing Genmab advances with lower dose of Rina-S in endometrial cancer trials
- The Motley Fool Why Genmab Stock Smashed It on Monday
- Investing Denmark stocks higher at close of trade; OMX Copenhagen 20 up 2.48%
- Investing Transactions in Connection with Share Buy-back Program
- Investing RBC Capital cuts Genmab stock target to DKK2,000; keeps Outperform
- Investing Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.59%
Rango diario
21.53
21.89
Rango anual
17.23
28.54
- Cierres anteriores
- 21.58
- Open
- 21.68
- Bid
- 21.86
- Ask
- 22.16
- Low
- 21.53
- High
- 21.89
- Volumen
- 2.796 K
- Cambio diario
- 0.83%
- Cambio mensual
- 6.74%
- Cambio a 6 meses
- 14.45%
- Cambio anual
- -22.84%
11 julio, viernes
08:00
ALL
- Act.
- Pronós.
- Prev.
16:00
USD
17:00
USD
- Act.
- Pronós.
- Prev.
- 425
17:00
USD
- Act.
- Pronós.
- Prev.
- 539
18:00
USD
- Act.
- Pronós.
- $-137.2 B
- Prev.
- $-316.0 B
19:30
USD
- Act.
- Pronós.
- Prev.
- 33.7 K
19:30
USD
- Act.
- Pronós.
- Prev.
- 63.4 K
19:30
USD
- Act.
- Pronós.
- Prev.
- 202.0 K
19:30
USD
- Act.
- Pronós.
- Prev.
- 234.7 K
19:30
USD
- Act.
- Pronós.
- Prev.
- -86.8 K
19:30
USD
- Act.
- Pronós.
- Prev.
- 0.7 K
19:30
USD
- Act.
- Pronós.
- Prev.
- -155.5 K
19:30
USD
- Act.
- Pronós.
- Prev.
- -92.8 K
19:30
USD
- Act.
- Pronós.
- Prev.
- 41.3 K
19:30
USD
- Act.
- Pronós.
- Prev.
- -69.6 K
19:30
USD
- Act.
- Pronós.
- Prev.
- 27.1 K